AYYAN subscription, rights trading to start today

14/07/2024 Argaam Special
Logo ofAYYAN Investment Co.

Logo of AYYAN Investment Co.


The subscription period and tradable rights trading for AYYAN Investment Co. start today, July 11.

 

The rights trading will end on July 21, while the subscription process will close on July 24.

 

For More IPOs

 

The company will offer 20 million ordinary shares at SAR 10 per share through issuing priority rights shares worth SAR 200 million riyals, to increase in the company’s capital by 24.8% from SAR 806.36 million to SAR 1006.36 million.

 

The company's shareholders approved the board’s proposal of capital increase via a SAR 200 million rights issue during the extraordinary general meeting (EGM) on July 8.

 

According to the rights issue prospectus, AYYAN will use the proceeds to purchase medical devices and equipment for Al-Salam Hospital, affiliated with the subsidiary, Al-Salam Medical Services Co., as well as payment to suppliers of subsidiaries, Al Ahsa Medical Services and Al-Salam Medical Services. The company will also pay outstanding obligations to financial entities by its subsidiary, Al-Salam Medical Services. Additionally, it will pay operational expenses for the subsidiary, Al-Salam Medical Services.

 

Capital Increase Details

Current Capital

SAR 806.36 mln

Number of Shares

80.64 mln

New Capital

SAR 1.006 bln

Number of Shares

100.64 mln

Percentage of Capital Increase

24.80%

 

Rights Issue Details

Offered Shares

20 mln

Offer Price

SAR 10

Issue Size

SAR 200 mln

Eligibility Ratio

Each listed shareholder is entitled to subscribe to 0.2480 rights per share held

Record date

July 8 (Shareholders of record who are registered with Edaa by the end of the second trading day following the EGM)

Trading period

July 14-21, 2024

Subscription period

July 14-24, 2024

Offering Proceeds (SAR mln)

Purchase of medical devices and equipment for Al-Salam Hospital, affiliated with Al-Salam Medical Services Co. (a subsidiary)

20.0

Payment to suppliers of subsidiary companies (Al Ahsa Medical Services and Al-Salam Medical Services)

61.1

Payment of outstanding obligations to financial entities by its subsidiary Al-Salam Medical Services

45

Payment of operational expenses for its subsidiary Al-Salam Medical Services

67.9

Offering costs

6.0

Total

200

Financial advisor, lead manager and underwriter

Alinma Investment

 

 

Right-holders may exercise their subscription right, in whole or in part, to the new shares in proportion to the rights existing in their portfolios.

 

Any unsubscribed shares and fractional shares will be offered to institutional investors, in accordance with the details set in the prospectus.

 

Alinma Investment will underwrite the new shares that remain unsubscribed after the rump offering.

 

The company also drew attention of investors not willing to subscribe to the importance of selling the rights issue they hold during the specified trading period to avoid the resulting decline in the value of their investment portfolios as a result of not benefiting from their rights, whether by way of sale or subscription.

Comments {{getCommentCount()}}

Be the first to comment

loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.